<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2005-05-10" modified="2017-09-27" version="117">
<accession>Q86Y38</accession>
<accession>Q9H1B6</accession>
<name>XYLT1_HUMAN</name>
<protein>
<recommendedName>
<fullName>Xylosyltransferase 1</fullName>
<ecNumber evidence="6">2.4.2.26</ecNumber>
</recommendedName>
<alternativeName>
<fullName>Peptide O-xylosyltransferase 1</fullName>
</alternativeName>
<alternativeName>
<fullName>Xylosyltransferase I</fullName>
<shortName>XT-I</shortName>
<shortName>XylT-I</shortName>
</alternativeName>
</protein>
<gene>
<name type="primary">XYLT1</name>
<name type="synonym">XT1</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="2005" name="Biochem. J." volume="386" first="227" last="236">
<title>Human xylosyltransferase I: functional and biochemical characterization of cysteine residues required for enzymic activity.</title>
<authorList>
<person name="Mueller S."/>
<person name="Schoettler M."/>
<person name="Schoen S."/>
<person name="Prante C."/>
<person name="Brinkmann T."/>
<person name="Kuhn J."/>
<person name="Goetting C."/>
<person name="Kleesiek K."/>
</authorList>
<dbReference type="PubMed" id="15461586"/>
<dbReference type="DOI" id="10.1042/BJ20041206"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>FUNCTION</scope>
<scope>DISULFIDE BONDS</scope>
<scope>COFACTOR</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>BIOPHYSICOCHEMICAL PROPERTIES</scope>
<scope>SUBUNIT</scope>
<scope>MUTAGENESIS OF CYS-257; CYS-276; CYS-285; CYS-301; CYS-471; CYS-542; CYS-561; CYS-563; CYS-572; CYS-574; CYS-675; CYS-920; CYS-927 AND CYS-933</scope>
</reference>
<reference key="2">
<citation type="journal article" date="2000" name="J. Mol. Biol." volume="304" first="517" last="528">
<title>Molecular cloning and expression of human UDP-D-xylose:proteoglycan core protein beta-D-xylosyltransferase and its first isoform XT-II.</title>
<authorList>
<person name="Goetting C."/>
<person name="Kuhn J."/>
<person name="Zahn R."/>
<person name="Brinkmann T."/>
<person name="Kleesiek K."/>
</authorList>
<dbReference type="PubMed" id="11099377"/>
<dbReference type="DOI" id="10.1006/jmbi.2000.4261"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 133-959</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="3">
<citation type="journal article" date="2001" name="J. Biol. Chem." volume="276" first="4940" last="4947">
<title>First isolation of human UDP-D-xylose: proteoglycan core protein beta-D-xylosyltransferase secreted from cultured JAR choriocarcinoma cells.</title>
<authorList>
<person name="Kuhn J."/>
<person name="Goetting C."/>
<person name="Schnoelzer M."/>
<person name="Kempf T."/>
<person name="Brinkmann T."/>
<person name="Kleesiek K."/>
</authorList>
<dbReference type="PubMed" id="11087729"/>
<dbReference type="DOI" id="10.1074/jbc.M005111200"/>
</citation>
<scope>PROTEIN SEQUENCE OF 159-171; 185-202; 289-296; 444-449; 593-598; 727-748 AND 948-959</scope>
<scope>GLYCOSYLATION</scope>
</reference>
<reference key="4">
<citation type="journal article" date="1999" name="J. Invest. Dermatol." volume="112" first="919" last="924">
<title>Serum xylosyltransferase: a new biochemical marker of the sclerotic process in systemic sclerosis.</title>
<authorList>
<person name="Goetting C."/>
<person name="Sollberg S."/>
<person name="Kuhn J."/>
<person name="Weilke C."/>
<person name="Huerkamp C."/>
<person name="Brinkmann T."/>
<person name="Krieg T."/>
<person name="Kleesiek K."/>
</authorList>
<dbReference type="PubMed" id="10383739"/>
<dbReference type="DOI" id="10.1046/j.1523-1747.1999.00590.x"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="5">
<citation type="journal article" date="2002" name="Clin. Chim. Acta" volume="317" first="199" last="202">
<title>Xylosyltransferase activity in seminal plasma of infertile men.</title>
<authorList>
<person name="Goetting C."/>
<person name="Kuhn J."/>
<person name="Brinkmann T."/>
<person name="Kleesiek K."/>
</authorList>
<dbReference type="PubMed" id="11814476"/>
<dbReference type="DOI" id="10.1016/S0009-8981(01)00793-8"/>
</citation>
<scope>REDUCED ACTIVITY IN SEMINAL PLASMA</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2004" name="J. Biol. Chem." volume="279" first="42566" last="42573">
<title>Analysis of the DXD motifs in human xylosyltransferase I required for enzyme activity.</title>
<authorList>
<person name="Goetting C."/>
<person name="Mueller S."/>
<person name="Schoettler M."/>
<person name="Schoen S."/>
<person name="Prante C."/>
<person name="Brinkmann T."/>
<person name="Kuhn J."/>
<person name="Kleesiek K."/>
</authorList>
<dbReference type="PubMed" id="15294915"/>
<dbReference type="DOI" id="10.1074/jbc.M401340200"/>
</citation>
<scope>BIOPHYSICOCHEMICAL PROPERTIES</scope>
<scope>COFACTOR</scope>
<scope>MUTAGENESIS OF ASP-314; ASP-316; ASP-745; TRP-746 AND ASP-747</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2006" name="J. Med. Genet." volume="43" first="745" last="749">
<title>Polymorphisms in the xylosyltransferase genes cause higher serum XT-I activity in patients with pseudoxanthoma elasticum (PXE) and are involved in a severe disease course.</title>
<authorList>
<person name="Schon S."/>
<person name="Schulz V."/>
<person name="Prante C."/>
<person name="Hendig D."/>
<person name="Szliska C."/>
<person name="Kuhn J."/>
<person name="Kleesiek K."/>
<person name="Gotting C."/>
</authorList>
<dbReference type="PubMed" id="16571645"/>
<dbReference type="DOI" id="10.1136/jmg.2006.040972"/>
</citation>
<scope>INVOLVEMENT IN PXE</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>VARIANT PXE SER-115</scope>
<scope>VARIANTS TRP-406 AND MET-665</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2014" name="Am. J. Hum. Genet." volume="94" first="405" last="414">
<title>XYLT1 mutations in Desbuquois dysplasia type 2.</title>
<authorList>
<person name="Bui C."/>
<person name="Huber C."/>
<person name="Tuysuz B."/>
<person name="Alanay Y."/>
<person name="Bole-Feysot C."/>
<person name="Leroy J.G."/>
<person name="Mortier G."/>
<person name="Nitschke P."/>
<person name="Munnich A."/>
<person name="Cormier-Daire V."/>
</authorList>
<dbReference type="PubMed" id="24581741"/>
<dbReference type="DOI" id="10.1016/j.ajhg.2014.01.020"/>
</citation>
<scope>VARIANT DBQD2 CYS-598</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2014" name="Hum. Genet." volume="133" first="29" last="39">
<title>The missing 'link': an autosomal recessive short stature syndrome caused by a hypofunctional XYLT1 mutation.</title>
<authorList>
<person name="Schreml J."/>
<person name="Durmaz B."/>
<person name="Cogulu O."/>
<person name="Keupp K."/>
<person name="Beleggia F."/>
<person name="Pohl E."/>
<person name="Milz E."/>
<person name="Coker M."/>
<person name="Ucar S.K."/>
<person name="Nurnberg G."/>
<person name="Nurnberg P."/>
<person name="Kuhn J."/>
<person name="Ozkinay F."/>
</authorList>
<dbReference type="PubMed" id="23982343"/>
<dbReference type="DOI" id="10.1007/s00439-013-1351-y"/>
</citation>
<scope>VARIANT DBQD2 TRP-481</scope>
</reference>
<comment type="function">
<text evidence="6">Catalyzes the first step in biosynthesis of glycosaminoglycan. Transfers D-xylose from UDP-D-xylose to specific serine residues of the core protein. Initial enzyme in the biosynthesis of chondroitin sulfate and dermatan sulfate proteoglycans in fibroblasts and chondrocytes.</text>
</comment>
<comment type="catalytic activity">
<text evidence="6">UDP-alpha-D-xylose + [protein]-L-serine = UDP + [protein]-3-O-(beta-D-xylosyl)-L-serine.</text>
</comment>
<comment type="cofactor">
<cofactor evidence="5 6">
<name>a divalent metal cation</name>
<dbReference type="ChEBI" id="CHEBI:60240"/>
</cofactor>
</comment>
<comment type="biophysicochemical properties">
<kinetics>
<KM evidence="5 6">0.9 uM for recombinant bikunin</KM>
<Vmax evidence="5 6">764 pmol/h/mg enzyme with recombinant bikunin as substrate</Vmax>
</kinetics>
</comment>
<comment type="pathway">
<text>Glycan metabolism; chondroitin sulfate biosynthesis.</text>
</comment>
<comment type="pathway">
<text>Glycan metabolism; heparan sulfate biosynthesis.</text>
</comment>
<comment type="subunit">
<text evidence="6">Monomer.</text>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="1">Endoplasmic reticulum membrane</location>
<topology evidence="1">Single-pass type II membrane protein</topology>
</subcellularLocation>
<subcellularLocation>
<location evidence="7">Golgi apparatus membrane</location>
<topology evidence="1">Single-pass type II membrane protein</topology>
</subcellularLocation>
<subcellularLocation>
<location evidence="11">Secreted</location>
</subcellularLocation>
<text>Some fraction is also found in the extracellular space together with chondroitin sulfate proteoglycans, suggesting that it can be secreted.</text>
</comment>
<comment type="tissue specificity">
<text evidence="4">Widely expressed. Expressed at higher level in placenta, kidney and pancreas. Weakly expressed in skeletal muscle.</text>
</comment>
<comment type="PTM">
<text>Contains 7 disulfide bonds.</text>
</comment>
<comment type="PTM">
<text evidence="3">N-glycosylated.</text>
</comment>
<comment type="disease" evidence="8 9">
<disease id="DI-04114">
<name>Desbuquois dysplasia 2</name>
<acronym>DBQD2</acronym>
<description>A chondrodysplasia characterized by severe prenatal and postnatal growth retardation (less than -5 SD), joint laxity, short extremities, progressive scoliosis, round face, midface hypoplasia, prominent bulging eyes. The main radiologic features are short long bones with metaphyseal splay, a 'Swedish key' appearance of the proximal femur (exaggerated trochanter), and advance carpal and tarsal bone age. Two forms of Desbuquois dysplasia are distinguished on the basis of the presence or absence of characteristic hand anomalies: an extra ossification center distal to the second metacarpal, delta phalanx, bifid distal thumb phalanx, and phalangeal dislocations.</description>
<dbReference type="MIM" id="615777"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="7">
<disease id="DI-00959">
<name>Pseudoxanthoma elasticum</name>
<acronym>PXE</acronym>
<description>A multisystem disorder characterized by accumulation of mineralized and fragmented elastic fibers in the skin, vascular walls, and Burch membrane in the eye. Clinically, patients exhibit characteristic lesions of the posterior segment of the eye including peau d'orange, angioid streaks, and choroidal neovascularizations, of the skin including soft, ivory colored papules in a reticular pattern that predominantly affect the neck and large flexor surfaces, and of the cardiovascular system with peripheral and coronary arterial occlusive disease as well as gastrointestinal bleedings.</description>
<dbReference type="MIM" id="264800"/>
</disease>
<text>The gene represented in this entry acts as a disease modifier.</text>
</comment>
<comment type="miscellaneous">
<text>Activity is strongly reduced in seminal plasma of unfertile men.</text>
</comment>
<comment type="similarity">
<text evidence="10">Belongs to the glycosyltransferase 14 family. XylT subfamily.</text>
</comment>
<dbReference type="EC" id="2.4.2.26" evidence="6"/>
<dbReference type="EMBL" id="AJ539163">
<property type="protein sequence ID" value="CAD62248.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AJ277441">
<property type="protein sequence ID" value="CAC16787.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS10569.1"/>
<dbReference type="RefSeq" id="NP_071449.1">
<property type="nucleotide sequence ID" value="NM_022166.3"/>
</dbReference>
<dbReference type="UniGene" id="Hs.22907"/>
<dbReference type="ProteinModelPortal" id="Q86Y38"/>
<dbReference type="BioGrid" id="122080">
<property type="interactions" value="3"/>
</dbReference>
<dbReference type="IntAct" id="Q86Y38">
<property type="interactions" value="2"/>
</dbReference>
<dbReference type="STRING" id="9606.ENSP00000261381"/>
<dbReference type="CAZy" id="GT14">
<property type="family name" value="Glycosyltransferase Family 14"/>
</dbReference>
<dbReference type="iPTMnet" id="Q86Y38"/>
<dbReference type="PhosphoSitePlus" id="Q86Y38"/>
<dbReference type="BioMuta" id="XYLT1"/>
<dbReference type="DMDM" id="71164803"/>
<dbReference type="EPD" id="Q86Y38"/>
<dbReference type="MaxQB" id="Q86Y38"/>
<dbReference type="PaxDb" id="Q86Y38"/>
<dbReference type="PeptideAtlas" id="Q86Y38"/>
<dbReference type="PRIDE" id="Q86Y38"/>
<dbReference type="Ensembl" id="ENST00000261381">
<property type="protein sequence ID" value="ENSP00000261381"/>
<property type="gene ID" value="ENSG00000103489"/>
</dbReference>
<dbReference type="GeneID" id="64131"/>
<dbReference type="KEGG" id="hsa:64131"/>
<dbReference type="UCSC" id="uc002dfa.4">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="64131"/>
<dbReference type="DisGeNET" id="64131"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000103489.11"/>
<dbReference type="GeneCards" id="XYLT1"/>
<dbReference type="HGNC" id="HGNC:15516">
<property type="gene designation" value="XYLT1"/>
</dbReference>
<dbReference type="HPA" id="HPA007478"/>
<dbReference type="HPA" id="HPA007966"/>
<dbReference type="MalaCards" id="XYLT1"/>
<dbReference type="MIM" id="264800">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="608124">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="615777">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q86Y38"/>
<dbReference type="OpenTargets" id="ENSG00000103489"/>
<dbReference type="Orphanet" id="1425">
<property type="disease" value="Desbuquois syndrome"/>
</dbReference>
<dbReference type="Orphanet" id="370930">
<property type="disease" value="XYLT1-CDG"/>
</dbReference>
<dbReference type="PharmGKB" id="PA37973"/>
<dbReference type="eggNOG" id="KOG0799">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="ENOG410XQ7M">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00760000119183"/>
<dbReference type="HOGENOM" id="HOG000070086"/>
<dbReference type="HOVERGEN" id="HBG059443"/>
<dbReference type="InParanoid" id="Q86Y38"/>
<dbReference type="KO" id="K00771"/>
<dbReference type="OMA" id="RMFKAIY"/>
<dbReference type="OrthoDB" id="EOG091G020K"/>
<dbReference type="PhylomeDB" id="Q86Y38"/>
<dbReference type="TreeFam" id="TF315534"/>
<dbReference type="BioCyc" id="MetaCyc:HS02509-MONOMER"/>
<dbReference type="BRENDA" id="2.4.2.26">
<property type="organism ID" value="2681"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1971475">
<property type="pathway name" value="A tetrasaccharide linker sequence is required for GAG synthesis"/>
</dbReference>
<dbReference type="SignaLink" id="Q86Y38"/>
<dbReference type="UniPathway" id="UPA00755"/>
<dbReference type="UniPathway" id="UPA00756"/>
<dbReference type="ChiTaRS" id="XYLT1">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="GeneWiki" id="XYLT1"/>
<dbReference type="GenomeRNAi" id="64131"/>
<dbReference type="PRO" id="PR:Q86Y38"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 16"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000103489"/>
<dbReference type="CleanEx" id="HS_XYLT1"/>
<dbReference type="Genevisible" id="Q86Y38">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005789">
<property type="term" value="C:endoplasmic reticulum membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0005576">
<property type="term" value="C:extracellular region"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0000139">
<property type="term" value="C:Golgi membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016021">
<property type="term" value="C:integral component of membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0008375">
<property type="term" value="F:acetylglucosaminyltransferase activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0030158">
<property type="term" value="F:protein xylosyltransferase activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030206">
<property type="term" value="P:chondroitin sulfate biosynthetic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-UniPathway"/>
</dbReference>
<dbReference type="GO" id="GO:0006024">
<property type="term" value="P:glycosaminoglycan biosynthetic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030203">
<property type="term" value="P:glycosaminoglycan metabolic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0015012">
<property type="term" value="P:heparan sulfate proteoglycan biosynthetic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-UniPathway"/>
</dbReference>
<dbReference type="InterPro" id="IPR003406">
<property type="entry name" value="Glyco_trans_14"/>
</dbReference>
<dbReference type="InterPro" id="IPR024448">
<property type="entry name" value="XylT"/>
</dbReference>
<dbReference type="Pfam" id="PF02485">
<property type="entry name" value="Branch"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF12529">
<property type="entry name" value="Xylo_C"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0903">Direct protein sequencing</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-1015">Disulfide bond</keyword>
<keyword id="KW-0242">Dwarfism</keyword>
<keyword id="KW-0256">Endoplasmic reticulum</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-0328">Glycosyltransferase</keyword>
<keyword id="KW-0333">Golgi apparatus</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0964">Secreted</keyword>
<keyword id="KW-0735">Signal-anchor</keyword>
<keyword id="KW-0808">Transferase</keyword>
<keyword id="KW-0812">Transmembrane</keyword>
<keyword id="KW-1133">Transmembrane helix</keyword>
<feature type="chain" description="Xylosyltransferase 1" id="PRO_0000191400">
<location>
<begin position="1"/>
<end position="959"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="2">
<location>
<begin position="1"/>
<end position="17"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical; Signal-anchor for type II membrane protein" evidence="2">
<location>
<begin position="18"/>
<end position="38"/>
</location>
</feature>
<feature type="topological domain" description="Lumenal" evidence="2">
<location>
<begin position="39"/>
<end position="959"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="2">
<location>
<position position="226"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="2">
<location>
<position position="421"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="2">
<location>
<position position="777"/>
</location>
</feature>
<feature type="sequence variant" description="In PXE; acts as a modifier of disease severity; results in higher serum xylosyltransferase activity; dbSNP:rs61758388." id="VAR_071271" evidence="7">
<original>A</original>
<variation>S</variation>
<location>
<position position="115"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs28709752." id="VAR_049324">
<original>P</original>
<variation>R</variation>
<location>
<position position="325"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs201009902." id="VAR_071272" evidence="7">
<original>R</original>
<variation>W</variation>
<location>
<position position="406"/>
</location>
</feature>
<feature type="sequence variant" description="In DBQD2; loss of predominance of Golgi localization in mutant cells; DCN in cell culture supernatant demonstrates glycosylation differences between patient and control cells; dbSNP:rs587777366." id="VAR_071273" evidence="8">
<original>R</original>
<variation>W</variation>
<location>
<position position="481"/>
</location>
</feature>
<feature type="sequence variant" description="In DBQD2; dbSNP:rs587777367." id="VAR_071274" evidence="9">
<original>R</original>
<variation>C</variation>
<location>
<position position="598"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs79030430." id="VAR_071275" evidence="7">
<original>T</original>
<variation>M</variation>
<location>
<position position="665"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs12325439." id="VAR_049325">
<original>P</original>
<variation>A</variation>
<location>
<position position="766"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs7200466." id="VAR_049326">
<original>V</original>
<variation>I</variation>
<location>
<position position="839"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs35309694." id="VAR_049327">
<original>R</original>
<variation>Q</variation>
<location>
<position position="892"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect." evidence="6">
<original>C</original>
<variation>A</variation>
<location>
<position position="257"/>
</location>
</feature>
<feature type="mutagenesis site" description="Strongly reduced enzyme activity." evidence="6">
<original>C</original>
<variation>A</variation>
<location>
<position position="276"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect." evidence="6">
<original>C</original>
<variation>A</variation>
<location>
<position position="285"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect." evidence="6">
<original>C</original>
<variation>A</variation>
<location>
<position position="301"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect." evidence="5">
<original>D</original>
<variation>G</variation>
<location>
<position position="314"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect." evidence="5">
<original>D</original>
<variation>G</variation>
<location>
<position position="316"/>
</location>
</feature>
<feature type="mutagenesis site" description="Strongly reduced enzyme activity." evidence="6">
<original>C</original>
<variation>A</variation>
<location>
<position position="471"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect." evidence="6">
<original>C</original>
<variation>A</variation>
<location>
<position position="542"/>
</location>
</feature>
<feature type="mutagenesis site" description="Strongly reduced enzyme activity." evidence="6">
<original>C</original>
<variation>A</variation>
<location>
<position position="561"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect." evidence="6">
<original>C</original>
<variation>A</variation>
<location>
<position position="563"/>
</location>
</feature>
<feature type="mutagenesis site" description="Strongly reduced enzyme activity." evidence="6">
<original>C</original>
<variation>A</variation>
<location>
<position position="572"/>
</location>
</feature>
<feature type="mutagenesis site" description="Strongly reduced enzyme activity." evidence="6">
<original>C</original>
<variation>A</variation>
<location>
<position position="574"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect." evidence="6">
<original>C</original>
<variation>A</variation>
<location>
<position position="675"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect." evidence="5">
<original>D</original>
<variation>E</variation>
<location>
<position position="745"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes enzyme activity but does not affect UDP-binding." evidence="5">
<original>D</original>
<variation>G</variation>
<location>
<position position="745"/>
</location>
</feature>
<feature type="mutagenesis site" description="Strongly reduced enzyme activity but does not affect UDP-binding." evidence="5">
<original>W</original>
<variation>D</variation>
<variation>N</variation>
<variation>G</variation>
<location>
<position position="746"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduced enzyme activity but does not affect UDP-binding." evidence="5">
<original>D</original>
<variation>G</variation>
<variation>E</variation>
<location>
<position position="747"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect." evidence="6">
<original>C</original>
<variation>A</variation>
<location>
<position position="920"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect." evidence="6">
<original>C</original>
<variation>A</variation>
<location>
<position position="927"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect." evidence="6">
<original>C</original>
<variation>A</variation>
<location>
<position position="933"/>
</location>
</feature>
<evidence key="1" type="ECO:0000250"/>
<evidence key="2" type="ECO:0000255"/>
<evidence key="3" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11087729"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11099377"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15294915"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15461586"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16571645"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23982343"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24581741"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000305"/>
<evidence key="11" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="10383739"/>
</source>
</evidence>
<sequence length="959" mass="107569" checksum="056FC3F66EFD4D81" modified="2003-06-01" version="1">
MVAAPCARRLARRSHSALLAALTVLLLQTLVVWNFSSLDSGAGERRGGAAVGGGEQPPPA
PAPRRERRDLPAEPAAARGGGGGGGGGGGGRGPQARARGGGPGEPRGQQPASRGALPARA
LDPHPSPLITLETQDGYFSHRPKEKVRTDSNNENSVPKDFENVDNSNFAPRTQKQKHQPE
LAKKPPSRQKELLKRKLEQQEKGKGHTFPGKGPGEVLPPGDRAAANSSHGKDVSRPPHAR
KTGGSSPETKYDQPPKCDISGKEAISALSRAKSKHCRQEIGETYCRHKLGLLMPEKVTRF
CPLEGKANKNVQWDEDSVEYMPANPVRIAFVLVVHGRASRQLQRMFKAIYHKDHFYYIHV
DKRSNYLHRQVLQVSRQYSNVRVTPWRMATIWGGASLLSTYLQSMRDLLEMTDWPWDFFI
NLSAADYPIRTNDQLVAFLSRYRDMNFLKSHGRDNARFIRKQGLDRLFLECDAHMWRLGD
RRIPEGIAVDGGSDWFLLNRRFVEYVTFSTDDLVTKMKQFYSYTLLPAESFFHTVLENSP
HCDTMVDNNLRITNWNRKLGCKCQYKHIVDWCGCSPNDFKPQDFHRFQQTARPTFFARKF
EAVVNQEIIGQLDYYLYGNYPAGTPGLRSYWENVYDEPDGIHSLSDVTLTLYHSFARLGL
RRAETSLHTDGENSCRYYPMGHPASVHLYFLADRFQGFLIKHHATNLAVSKLETLETWVM
PKKVFKIASPPSDFGRLQFSEVGTDWDAKERLFRNFGGLLGPMDEPVGMQKWGKGPNVTV
TVIWVDPVNVIAATYDILIESTAEFTHYKPPLNLPLRPGVWTVKILHHWVPVAETKFLVA
PLTFSNRQPIKPEEALKLHNGPLRNAYMEQSFQSLNPVLSLPINPAQVEQARRNAASTGT
ALEGWLDSLVGGMWTAMDICATGPTACPVMQTCSQTAWSSFSPDPKSELGAVKPDGRLR
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>